Accelerate Diagnostics, Inc. Forecast, price target & analysts
Accelerate Diagnostics, Inc. Target price 2025 - Analyst rating & recommendation
There are currently no analyst estimates including target prices 2025, ratings or recommendations for the Accelerate Diagnostics, Inc. stock.
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 11.70 | 12.56 |
| 2.99% | 7.32% | |
| EBITDA Margin | -272.56% | -321.69% |
| 33.71% | 18.02% | |
| Net Margin | -427.78% | -409.27% |
| 16.28% | 4.33% |
3 Analysts have issued a sales forecast Accelerate Diagnostics, Inc. 2025 . The average Accelerate Diagnostics, Inc. sales estimate is
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $11.7m | 2.99% |
|---|---|---|
| 2025 |
$12.6m
7.32%
Unlock
|
|
3 Analysts have issued an Accelerate Diagnostics, Inc. EBITDA forecast 2025. The average Accelerate Diagnostics, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $-31.9m | 35.69% |
|---|---|---|
| 2025 |
$-40.4m
26.66%
Unlock
|
|
EBITDA Margin
| 2024 | -272.56% | 33.71% |
|---|---|---|
| 2025 |
-321.69%
18.02%
Unlock
|
|
3 Accelerate Diagnostics, Inc. Analysts have issued a net profit forecast 2025. The average Accelerate Diagnostics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $-50.1m | 18.78% |
|---|---|---|
| 2025 |
$-51.4m
2.68%
Unlock
|
|
Net Margin
| 2024 | -427.78% | 16.28% |
|---|---|---|
| 2025 |
-409.27%
4.33%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.15 | -2.04 |
| 56.48% | 5.12% | |
| P/E | 0.00 | |
| EV/Sales | 3.78 |
3 Analysts have issued a Accelerate Diagnostics, Inc. forecast for earnings per share. The average Accelerate Diagnostics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $-2.15 | 56.48% |
|---|---|---|
| 2025 |
$-2.04
5.12%
Unlock
|
|
P/E ratio
| Current | 0.00 | 100.00% |
|---|
Based on analysts' sales estimates for 2025, the Accelerate Diagnostics, Inc. stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 4.05 | 24.86% |
|---|---|---|
| 2025 |
3.78
6.71%
Unlock
|
|
P/S ratio
| Current | 0.02 | 99.21% |
|---|---|---|
| 2025 |
0.02
6.76%
Unlock
|
|
Accelerate Diagnostics, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
